pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Newly elected scientists aim to restore health equity programs cut by Trump administration

Nov 6, 2026·read at STAT ↗Positive

Two newly elected officials with scientific credentials, Michigan Senator-elect Abdul El-Sayed, an epidemiologist, and Georgia Rep-elect Jasmine Clark, a microbiologist, are preparing to join Congress.

They point to a wave of Trump-era actions that eliminated hundreds of grants targeting medical disparities, closed initiatives to diversify the scientific workforce, and launched investigations into universities accused of bias.

Both lawmakers say their research backgrounds will guide efforts to revive those health-equity programs and protect funding for studies that address disparities.

Democrats now control the 120th Congress, but with President Trump still able to veto legislation, the pair acknowledge that restoring the programs will require navigating a complex political landscape.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Two incoming lawmakers plan to defend health equity from Trump administration cuts”

read at STAT ↗
1,206 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health
drugs
hepatitis B vaccine
topics
OphthalmologyVaccine

related stories

  • Sep 15Businesses can now apply for NIH fundingSTAT
  • Jun 11Opinion: How long Covid’s scientific stalemate made it politically erasableSTAT
  • May 5What you need to know about hantavirus (don’t panic)STAT
  • May 1PFAS is still in some infant formulaSTAT
  • Apr 27Opinion: I’m a fourth-year med student, but I only learned one historical example of medical racismSTAT